Siemens plans to transfer 30% of its stake in Siemens Healthineers to shareholders, deconsolidating the business for greater agility and focus. This move aims to enhance transparency, reduce complexity, and simplify governance structures, according to Siemens’ president and CEO Roland Busch. The transaction is subject to regulatory approvals and shareholder meetings.

Siemens Healthineers reported strong performance, with EBIT close to €3.9bn in FY25 and expected revenue growth of 5%-6% in FY26. The deconsolidation decision may be influenced by the high risk and regulatory costs associated with the healthcare industry, as suggested by industry analysts. Siemens and Healthineers will work closely on structuring the transaction.

Siemens Healthineers is considering an exit from its diagnostics division, creating more freedom and optionality for the business. CEO Bernd Montag revealed this plan during a capital markets day event, indicating a potential strategic shift towards standalone operations. Siemens’ deconsolidation move aligns with Healthineers’ future plans in the healthcare sector.

Read more at Yahoo Finance: Siemens to exit healthcare space with Healthineers deconsolidation